Trial Outcomes & Findings for Comparative Clinical Evaluation of Daily Disposable Lenses in Symptomatic Lens Wearers (NCT NCT00953407)
NCT ID: NCT00953407
Last Updated: 2012-07-10
Results Overview
Lens awareness, as interpreted by the subject, was reported by the subject as a single, retrospective evaluation of 4 week's wear time. Frequency of lens awareness was measured on a 4-point scale, with 1 being never and 4 being all the time. Four-week ratings were compared to baseline ratings, and a negative difference (4-week minus baseline) represented an improvement.
COMPLETED
NA
128 participants
4 weeks of wear
2012-07-10
Participant Flow
Two participants were enrolled but not dispensed due to failing inclusion/exclusion criteria. These participants were included in the Actual Enrollment calculation, but not Participant Flow or Baseline Characteristics calculations.
Participant milestones
| Measure |
Nelfilcon A
Nelfilcon A contact lens
|
Narafilcon A
Narafilcon A contact lens
|
Etafilcon A
Etafilcon A contact lens
|
Omafilcon A
Omafilcon A contact lens
|
Hilafilcon B
Hilafilcon B contact lens
|
|---|---|---|---|---|---|
|
Overall Study
STARTED
|
26
|
25
|
26
|
25
|
24
|
|
Overall Study
COMPLETED
|
25
|
24
|
25
|
23
|
23
|
|
Overall Study
NOT COMPLETED
|
1
|
1
|
1
|
2
|
1
|
Reasons for withdrawal
| Measure |
Nelfilcon A
Nelfilcon A contact lens
|
Narafilcon A
Narafilcon A contact lens
|
Etafilcon A
Etafilcon A contact lens
|
Omafilcon A
Omafilcon A contact lens
|
Hilafilcon B
Hilafilcon B contact lens
|
|---|---|---|---|---|---|
|
Overall Study
Failed inclusion criteria
|
1
|
1
|
1
|
1
|
1
|
|
Overall Study
Lost to Follow-up
|
0
|
0
|
0
|
1
|
0
|
Baseline Characteristics
Comparative Clinical Evaluation of Daily Disposable Lenses in Symptomatic Lens Wearers
Baseline characteristics by cohort
| Measure |
Nelfilcon A
n=26 Participants
Nelfilcon A spherical contact lens worn on a daily wear, daily disposable basis
|
Narafilcon A
n=25 Participants
Narafilcon A spherical contact lens worn on a daily wear, daily disposable basis
|
Etafilcon A
n=26 Participants
Etafilcon A spherical contact lens worn on a daily wear, daily disposable basis
|
Omafilcon A
n=25 Participants
Omafilcon A spherical contact lens worn on a daily wear, daily disposable basis
|
Hilafilcon B
n=24 Participants
Hilafilcon B spherical contact lens worn on a daily wear, daily disposable basis
|
Total
n=126 Participants
Total of all reporting groups
|
|---|---|---|---|---|---|---|
|
Age Continuous
|
29.5 years
STANDARD_DEVIATION 7.0 • n=93 Participants
|
31.5 years
STANDARD_DEVIATION 11.9 • n=4 Participants
|
29.9 years
STANDARD_DEVIATION 10.1 • n=27 Participants
|
28.3 years
STANDARD_DEVIATION 7.7 • n=483 Participants
|
30.5 years
STANDARD_DEVIATION 9.6 • n=36 Participants
|
29.9 years
STANDARD_DEVIATION 9.3 • n=10 Participants
|
|
Sex: Female, Male
Female
|
18 Participants
n=93 Participants
|
15 Participants
n=4 Participants
|
20 Participants
n=27 Participants
|
19 Participants
n=483 Participants
|
17 Participants
n=36 Participants
|
89 Participants
n=10 Participants
|
|
Sex: Female, Male
Male
|
8 Participants
n=93 Participants
|
10 Participants
n=4 Participants
|
6 Participants
n=27 Participants
|
6 Participants
n=483 Participants
|
7 Participants
n=36 Participants
|
37 Participants
n=10 Participants
|
PRIMARY outcome
Timeframe: 4 weeks of wearPopulation: Per protocol. Analysis excluded major protocol deviations as determined by masked review.
Lens awareness, as interpreted by the subject, was reported by the subject as a single, retrospective evaluation of 4 week's wear time. Frequency of lens awareness was measured on a 4-point scale, with 1 being never and 4 being all the time. Four-week ratings were compared to baseline ratings, and a negative difference (4-week minus baseline) represented an improvement.
Outcome measures
| Measure |
Nelfilcon A
n=25 Participants
Nelfilcon A contact lens
|
Narafilcon A
n=24 Participants
Narafilcon A contact lens
|
Etafilcon A
n=24 Participants
Etafilcon A contact lens
|
Omafilcon A
n=23 Participants
Omafilcon A contact lens
|
Hilafilcon B
n=23 Participants
Hilafilcon B contact lens
|
|---|---|---|---|---|---|
|
Lens Awareness
|
16 Participants
2.3
|
12 Participants
2.8
|
11 Participants
3.1
|
9 Participants
2.5
|
13 Participants
3.1
|
Adverse Events
Nelfilcon A
Narafilcon A
Etafilcon A
Omafilcon A
Hilafilcon B
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs
CIBA VISION
Results disclosure agreements
- Principal investigator is a sponsor employee For a period of 10 years, the clinical investigator must hold all trial-related information and documents confidential and must agree to obtain sponsor's written consent before discussing, presenting, publicizing, or otherwise disclosing any preclinical and/or clinical data or impressions from this trial.
- Publication restrictions are in place
Restriction type: OTHER